Secretome-based identification and characterization of potential biomarkers in thyroid cancer

Journal of Proteome Research

Volumn 9, Issue 11, 2010, Pages 5757-5769

  Kashat, Lawrence ^a,b   So, Anthony K C ^a   Masui, Olena ^c   Wang, X Simon ^c   Cao, Jun ^a   Meng, Xianwang ^a   MacMillan, Christina ^a   Ailles, Laurie E ^d   Siu, K W Michael ^c   Ralhan, Ranju ^a,b,c,e   Walfish, Paul G ^a,b,e  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c YORK UNIVERSITY   (Canada)

^d PRINCESS MARGARET HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

biomarkers; one dimensional liquid chromatography tandem mass spectrometry; proteomics; secretome; secretory proteins; thyroid cancer

Indexed keywords

BIOLOGICAL MARKER; BIOTINIDASE; CLUSTERIN; CYSTEINE RICH PROTEIN 61; ENOLASE; NUCLEOLIN; PROTHYMOSIN ALPHA;

ANAPLASTIC CARCINOMA; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CANCER CELL CULTURE; CANCER TISSUE; CELL NUCLEUS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TANDEM MASS SPECTROMETRY; THYROID CANCER; THYROID PAPILLARY CARCINOMA; TUMOR DIFFERENTIATION; TUMOR XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; CLUSTERIN; CYSTEINE-RICH PROTEIN 61; DNA-BINDING PROTEINS; HUMANS; MICE; MICE, SCID; NEOPLASM PROTEINS; PHOSPHOPROTEINS; PHOSPHOPYRUVATE HYDRATASE; PROTEOMICS; QUATERNARY AMMONIUM COMPOUNDS; RNA-BINDING PROTEINS; THYROID NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

MUS;

EID: 78149379326     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr100529t     Document Type: Article

References (80)

1. Reis, E. M.; Ojopi, E. P.; Alberto, F. L.; Rahal, P.; Tsukumo, F.; Mancini, U. M.; Guimaraes, G. S.; Thompson, G. M.; Camacho, C.; Miracca, E.; Carvalho, A. L.; Machado, A. A.; Paquola, A. C.; Cerutti, J. M.; da Silva, A. M.; Pereira, G. G.; Valentini, S. R.; Nagai, M. A.; Kowalski, L. P.; Verjovski-Almeida, S.; Tajara, E. H.; Dias-Neto, E.; Bengtson, M. H.; Canevari, R. A.; Carazzolle, M. F.; Colin, C.; Costa, F. F.; Costa, M. C.; Estecio, M. R.; Esteves, L. I.; Federico, M. H.; Guimaraes, P. E.; Hackel, C.; Kimura, E. T.; Leoni, S. G.; Maciel, R. M.; Maistro, S.; Mangone, F. R.; Massirer, K. B.; Matsuo, S. E.; Nobrega, F. G.; Nobrega, M. P.; Nunes, D. N.; Nunes, F.; Pandolfi, J. R.; Pardini, M. I.; Pasini, F. S.; Peres, T.; Rainho, C. A.; dos Reis, P. P.; Rodrigus-Lisoni, F. C.; Rogatto, S. R.; dos Santos, A.; dos Santos, P. C.; Sogayar, M. C.; Zanelli, C. F. Large-scale transcriptome analyses reveal new genetic marker candidates of head, neck, and thyroid cancer Cancer Res. 2005, 65 (5) 1693-9
2. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Murray, T.; Thun, M. J. Cancer statistics, 2008 CA Cancer J. Clin. 2008, 58 (2) 71-96
3. Carpi, A.; Di Coscio, G.; Iervasi, G.; Antonelli, A.; Mechanick, J.; Sciacchitano, S.; Nicolini, A. Thyroid fine needle aspiration: how to improve clinicians' confidence and performance with the technique Cancer Lett. 2008, 264 (2) 163-71
4. Nikiforova, M. N.; Nikiforov, Y. E. Molecular diagnostics and predictors in thyroid cancer Thyroid 2009, 19 (12) 1351-61
5. Damante, G. S., A.; Tell, G. Thyroid Tumors: novel insights from proteomics studies Expert Rev. Proteomics 2009, 6 (4) 363-76
6. Chung, L. W.; Baseman, A.; Assikis, V.; Zhau, H. E. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment J. Urol. 2005, 173 (1) 10-20
7. Liotta, L. A.; Ferrari, M.; Petricoin, E. Clinical proteomics: written in blood Nature 2003, 425 (6961) 905
8. Villanueva, J.; Nazarian, A.; Lawlor, K.; Yi, S. S.; Robbins, R. J.; Tempst, P. A sequence-specific exopeptidase activity test (SSEAT) for "functional" biomarker discovery Mol. Cell. Proteomics 2008, 7 (3) 509-18
9. Rifai, N.; Gillette, M. A.; Carr, S. A. Protein biomarker discovery and validation: the long and uncertain path to clinical utility Nat. Biotechnol. 2006, 24 (8) 971-83
10. Hu, S.; Arellano, M.; Boontheung, P.; Wang, J.; Zhou, H.; Jiang, J.; Elashoff, D.; Wei, R.; Loo, J. A.; Wong, D. T. Salivary proteomics for oral cancer biomarker discovery Clin. Cancer Res. 2008, 14 (19) 6246-52
11. DeSouza, L. V.; Grigull, J.; Ghanny, S.; Dube, V.; Romaschin, A. D.; Colgan, T. J.; Siu, K. W. Endometrial carcinoma biomarker discovery and verification using differentially tagged clinical samples with multidimensional liquid chromatography and tandem mass spectrometry Mol. Cell. Proteomics 2007, 6 (7) 1170-82
12. Volmer, M. W.; Stuhler, K.; Zapatka, M.; Schoneck, A.; Klein-Scory, S.; Schmiegel, W.; Meyer, H. E.; Schwarte-Waldhoff, I. Differential proteome analysis of conditioned media to detect Smad4 regulated secreted biomarkers in colon cancer Proteomics 2005, 5 (10) 2587-601
13. Sardana, G.; Jung, K.; Stephan, C.; Diamandis, E. P. Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers J. Proteome Res. 2008, 7 (8) 3329-38
14. Kulasingam, V.; Diamandis, E. P. Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets Mol. Cell. Proteomics 2007, 6 (11) 1997-2011
15. Lawlor, K.; Nazarian, A.; Lacomis, L.; Tempst, P.; Villanueva, J. Pathway-based biomarker search by high-throughput proteomics profiling of secretomes J. Proteome Res. 2009, 8 (3) 1489-503
16. Gourin, C. G.; Zhi, W.; Adam, B. L. Proteomic identification of serum biomarkers for head and neck cancer surveillance Laryngoscope 2009, 119 (7) 1291-302
17. Bijian, K.; Mlynarek, A. M.; Balys, R. L.; Jie, S.; Xu, Y.; Hier, M. P.; Black, M. J.; Di Falco, M. R.; LaBoissiere, S.; Alaoui-Jamali, M. A. Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment J. Proteome Res. 2009, 8 (5) 2173-85
18. Kuzyk, M. A.; Smith, D.; Yang, J.; Cross, T. J.; Jackson, A. M.; Hardie, D. B.; Anderson, N. L.; Borchers, C. H. Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma Mol. Cell. Proteomics 2009, 8 (8) 1860-77
19. Addona, T. A.; Abbatiello, S. E.; Schilling, B.; Skates, S. J.; Mani, D. R.; Bunk, D. M.; Spiegelman, C. H.; Zimmerman, L. J.; Ham, A. J.; Keshishian, H.; Hall, S. C.; Allen, S.; Blackman, R. K.; Borchers, C. H.; Buck, C.; Cardasis, H. L.; Cusack, M. P.; Dodder, N. G.; Gibson, B. W.; Held, J. M.; Hiltke, T.; Jackson, A.; Johansen, E. B.; Kinsinger, C. R.; Li, J.; Mesri, M.; Neubert, T. A.; Niles, R. K.; Pulsipher, T. C.; Ransohoff, D.; Rodriguez, H.; Rudnick, P. A.; Smith, D.; Tabb, D. L.; Tegeler, T. J.; Variyath, A. M.; Vega-Montoto, L. J.; Wahlander, A.; Waldemarson, S.; Wang, M.; Whiteaker, J. R.; Zhao, L.; Anderson, N. L.; Fisher, S. J.; Liebler, D. C.; Paulovich, A. G.; Regnier, F. E.; Tempst, P.; Carr, S. A. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma Nat. Biotechnol. 2009, 27 (7) 633-41
20. DeSouza, L. V.; Taylor, A. M.; Li, W.; Minkoff, M. S.; Romaschin, A. D.; Colgan, T. J.; Siu, K. W. Multiple reaction monitoring of mTRAQ-labeled peptides enables absolute quantification of endogenous levels of a potential cancer marker in cancerous and normal endometrial tissues J. Proteome Res. 2008, 7 (8) 3525-34
21. DeSouza, L. V.; Romaschin, A. D.; Colgan, T. J.; Siu, K. W. Absolute quantification of potential cancer markers in clinical tissue homogenates using multiple reaction monitoring on a hybrid triple quadrupole/linear ion trap tandem mass spectrometer Anal. Chem. 2009, 81 (9) 3462-70
22. Gioanni, J.; Zanghellini, E.; Mazeau, C.; Zhang, D.; Courdi, A.; Farges, M.; Lambert, J. C.; Duplay, H.; Schneider, M. [Characterization of a human cell line from an anaplastic carcinoma of the thyroid gland] Bull. Cancer 1991, 78 (11) 1053-62
23. Tanaka, J.; Ogura, T.; Sato, H.; Hatano, M. Establishment and biological characterization of an in vitro human cytomegalovirus latency model Virology 1987, 161 (1) 62-72
24. Schweppe, R. E.; Klopper, J. P.; Korch, C.; Pugazhenthi, U.; Benezra, M.; Knauf, J. A.; Fagin, J. A.; Marlow, L. A.; Copland, J. A.; Smallridge, R. C.; Haugen, B. R. Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification J. Clin. Endocrinol. Metab. 2008, 93 (11) 4331-41
25. Meireles, A. M.; Preto, A.; Rocha, A. S.; Rebocho, A. P.; Maximo, V.; Pereira-Castro, I.; Moreira, S.; Feijao, T.; Botelho, T.; Marques, R.; Trovisco, V.; Cirnes, L.; Alves, C.; Velho, S.; Soares, P.; Sobrinho-Simoes, M. Molecular and genotypic characterization of human thyroid follicular cell carcinoma-derived cell lines Thyroid 2007, 17 (8) 707-15
26. Al-Nedawi, K.; Szemraj, J.; Cierniewski, C. S. Mast cell-derived exosomes activate endothelial cells to secrete plasminogen activator inhibitor type 1 Arterioscler. Thromb. Vasc. Biol. 2005, 25 (8) 1744-9
27. DeSouza, L.; Diehl, G.; Rodrigues, M. J.; Guo, J.; Romaschin, A. D.; Colgan, T. J.; Siu, K. W. Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry J. Proteome Res. 2005, 4 (2) 377-86
28. Bendtsen, J. D.; Nielsen, H.; von Heijne, G.; Brunak, S. Improved prediction of signal peptides: SignalP 3.0 J. Mol. Biol. 2004, 340 (4) 783-95
29. Bendtsen, J. D.; Jensen, L. J.; Blom, N.; Von Heijne, G.; Brunak, S. Feature-based prediction of non-classical and leaderless protein secretion Protein Eng. Des. Sel. 2004, 17 (4) 349-56
30. Ralhan, R.; Desouza, L. V.; Matta, A.; Chandra Tripathi, S.; Ghanny, S.; Datta Gupta, S.; Bahadur, S.; Siu, K. W. Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry Mol. Cell. Proteomics 2008, 7 (6) 1162-73
31. Ito, M.; Hiramatsu, H.; Kobayashi, K.; Suzue, K.; Kawahata, M.; Hioki, K.; Ueyama, Y.; Koyanagi, Y.; Sugamura, K.; Tsuji, K.; Heike, T.; Nakahata, T. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells Blood 2002, 100 (9) 3175-82
32. Jou, Y.-C.; Tung, C.-L.; Tsai, Y.-S.; Shen, C.-H.; Syue-Yi, C.; Shiau, A.-L.; Tsai, H.-T.; Wu, C.-L.; Tzai, T.-S. Prognostic Relevance of Prothymosin-[alpha] Expression in Human Upper Urinary Tract Transitional Cell Carcinoma Urology 2009, 74 (4) 951-7
33. Letsas, K. P.; Vartholomatos, G.; Tsepi, C.; Tsatsoulis, A.; Frangou-Lazaridis, M. Fine-needle aspiration biopsy-RT-PCR expression analysis of prothymosin alpha and parathymosin in thyroid: novel proliferation markers Neoplasma 2007, 54 (1) 57-62
34. Suzuki, S.; Takahashi, S.; Takeshita, K.; Hikosaka, A.; Wakita, T.; Nishiyama, N.; Fujita, T.; Okamura, T.; Shirai, T. Expression of prothymosin alpha is correlated with development and progression in human prostate cancers Prostate 2006, 66 (5) 463-9
35. Tsai, Y. S.; Jou, Y. C.; Lee, G. F.; Chen, Y. C.; Shiau, A. L.; Tsai, H. T.; Wu, C. L.; Tzai, T. S. Aberrant prothymosin-alpha expression in human bladder cancer Urology 2009, 73 (1) 188-92
36. Destouches, D.; El Khoury, D.; Hamma-Kourbali, Y.; Krust, B.; Albanese, P.; Katsoris, P.; Guichard, G.; Briand, J. P.; Courty, J.; Hovanessian, A. G. Suppression of tumor growth and angiogenesis by a specific antagonist of the cell-surface expressed nucleolin PLoS One 2008, 3 (6 e2518
37. Soundararajan, S.; Wang, L.; Sridharan, V.; Chen, W.; Courtenay-Luck, N.; Jones, D.; Spicer, E. K.; Fernandes, D. J. Plasma membrane nucleolin is a receptor for the anticancer aptamer AS1411 in MV4-11 leukemia cells Mol. Pharmacol. 2009, 76 (5) 984-91
38. Tulchin N Fau-Chambon, M.; Chambon M Fau-Juan, G.; Juan G Fau-Dikman, S.; Dikman S Fau-Strauchen, J.; Strauchen J Fau-Ornstein, L.; Ornstein L Fau-Billack, B.; Billack B Fau-Woods, N. T.; Woods Nt Fau-Monteiro, A. N. A.; Monteiro, A. N., BRCA1 protein and nucleolin colocalize in breast carcinoma tissue and cancer cell lines. (1525-2191 (Electronic)).
39. Pucci, S.; Mazzarelli, P.; Nucci, C.; Ricci, F.; Spagnoli, L. G. CLU "in and out": looking for a link Adv. Cancer Res. 2009, 105, 93-113
40. Bi, J.; Guo, A. L.; Lai, Y. R.; Li, B.; Zhong, J. M.; Wu, H. Q.; Xie, Z.; He, Y. L.; Lv, Z. L.; Lau, S. H.; Wang, Q.; Huang, X. H.; Zhang, L. J.; Wen, J. M.; Guan, X. Y. Overexpression of clusterin correlates with tumor progression, metastasis in gastric cancer: a study on tissue microarrays Neoplasma 2010, 57 (3) 191-7
41. Chung, J.; Kwak, C.; Jin, R. J.; Lee, C. H.; Lee, K. H.; Lee, S. E. Enhanced chemosensitivity of bladder cancer cells to cisplatin by suppression of clusterin in vitro Cancer Lett. 2004, 203 (2) 155-61
42. Yang, G. F.; Li, X. M.; Xie, D. Overexpression of clusterin in ovarian cancer is correlated with impaired survival Int. J. Gynecol. Cancer 2009, 19 (8) 1342-6
43. Zoubeidi, A.; Ettinger, S.; Beraldi, E.; Hadaschik, B.; Zardan, A.; Klomp, L. W.; Nelson, C. C.; Rennie, P. S.; Gleave, M. E. Clusterin Facilitates COMMD1 and I-{kappa}B Degradation to Enhance NF-{kappa}B Activity in Prostate Cancer Cells Mol. Cancer Res. 2010
44. Franzen, C. A.; Chen, C. C.; Todorovic, V.; Juric, V.; Monzon, R. I.; Lau, L. F. Matrix protein CCN1 is critical for prostate carcinoma cell proliferation and TRAIL-induced apoptosis Mol. Cancer Res. 2009, 7 (7) 1045-55
45. Jiang, W.; Li, X.; Rao, S.; Wang, L.; Du, L.; Li, C.; Wu, C.; Wang, H.; Wang, Y.; Yang, B. Constructing disease-specific gene networks using pair-wise relevance metric: application to colon cancer identifies interleukin 8, desmin and enolase 1 as the central elements BMC Syst. Biol. 2008, 2, 72
46. Katanasaka, Y.; Asai, T.; Naitou, H.; Ohashi, N.; Oku, N. Proteomic characterization of angiogenic endothelial cells stimulated with cancer cell-conditioned medium Biol. Pharm. Bull. 2007, 30 (12) 2300-7
47. Kang, U.-B.; Ahn, Y.; Lee, J.; Kim, Y.-H.; Kim, J.; Yu, M.-H.; Noh, D.-Y.; Lee, C. Differential profiling of breast cancer plasma proteome by isotope-coded affinity tagging method reveals biotinidase as a breast cancer biomarker BMC Cancer 2010, 10 (1) 114
48. Chahed, K.; Kabbage, M.; Hamrita, B.; Guillier, C. L.; Trimeche, M.; Remadi, S.; Ehret-Sabatier, L.; Chouchane, L. Detection of protein alterations in male breast cancer using two dimensional gel electrophoresis and mass spectrometry: the involvement of several pathways in tumorigenesis Clin. Chim. Acta 2008, 388 (1-2) 106-14
49. Wasenius, V. M.; Hemmer, S.; Kettunen, E.; Knuutila, S.; Franssila, K.; Joensuu, H. Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study Clin. Cancer Res. 2003, 9 (1) 68-75
50. Sainaghi, P. P.; Castello, L.; Bergamasco, L.; Galletti, M.; Bellosta, P.; Avanzi, G. C. Gas6 induces proliferation in prostate carcinoma cell lines expressing the Axl receptor J. Cell Physiol. 2005, 204 (1) 36-44
51. Krause, K.; Karger, S.; Sheu, S. Y.; Aigner, T.; Kursawe, R.; Gimm, O.; Schmid, K. W.; Dralle, H.; Fuhrer, D. Evidence for a role of the amyloid precursor protein in thyroid carcinogenesis J. Endocrinol. 2008, 198 (2) 291-9
52. Fluge, O.; Bruland, O.; Akslen, L. A.; Lillehaug, J. R.; Varhaug, J. E. Gene expression in poorly differentiated papillary thyroid carcinomas Thyroid 2006, 16 (2) 161-75
53. Horvatic Herceg, G.; Herceg, D.; Kralik, M.; Bence-Zigman, Z.; Tomic-Brzac, H.; Kulic, A. Urokinase-type plasminogen activator and its inhibitor in thyroid neoplasms: a cytosol study Wien. Klin. Wochenschr. 2006, 118 (19-20) 601-9
54. Chu, Q. D.; Hurd, T. C.; Harvey, S.; Martinick, M.; Markus, G.; Tan, D.; Gibbs, J. F.; Loree, T. Overexpression of urinary plasminogen activator (uPA) protein and mRNA in thyroid carcinogenesis Diagn. Mol. Pathol. 2004, 13 (4) 241-6
55. Ghoneim, C.; Soula-Rothhut, M.; Blanchevoye, C.; Martiny, L.; Antonicelli, F.; Rothhut, B. Activating transcription factor-1-mediated hepatocyte growth factor-induced down-regulation of thrombospondin-1 expression leads to thyroid cancer cell invasion J. Biol. Chem. 2007, 282 (21) 15490-7
56. Sato, K.; Waseda, R.; Tatsuzawa, Y.; Soma, R.; Ueda, Y.; Katsuda, S. Papillary thyroid carcinoma with anaplastic transformation showing a rhabdoid phenotype solely in the cervical lymph node metastasis Pathol. Res. Pract. 2006, 202 (1) 55-9
57. Watanabe, R.; Hayashi, Y.; Sassa, M.; Kikumori, T.; Imai, T.; Kiuchi, T.; Murata, Y. Possible involvement of BRAFV600E in altered gene expression in papillary thyroid cancer Endocr. J. 2009, 56 (3) 407-14
58. Lassoued, S.; Mseddi, M.; Mnif, F.; Abid, M.; Guermazi, F.; Masmoudi, H.; El Feki, A.; Attia, H. A Comparative Study of the Oxidative Profile in Graves' Disease, Hashimoto's Thyroiditis, and Papillary Thyroid Cancer Biol. Trace Elem. Res. 2010
59. Aldred, M. A.; Huang, Y.; Liyanarachchi, S.; Pellegata, N. S.; Gimm, O.; Jhiang, S.; Davuluri, R. V.; de la Chapelle, A.; Eng, C. Papillary and follicular thyroid carcinomas show distinctly different microarray expression profiles and can be distinguished by a minimum of five genes J. Clin. Oncol. 2004, 22 (17) 3531-9
60. Fujarewicz, K.; Jarzab, M.; Eszlinger, M.; Krohn, K.; Paschke, R.; Oczko-Wojciechowska, M.; Wiench, M.; Kukulska, A.; Jarzab, B.; Swierniak, A. A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping Endocr. Relat. Cancer 2007, 14 (3) 809-26
61. Manetti, L.; Pardini, E.; Genovesi, M.; Campomori, A.; Grasso, L.; Morselli, L. L.; Lupi, I.; Pellegrini, G.; Bartalena, L.; Bogazzi, F.; Martino, E. Thyroid function differently affects serum cystatin C and creatinine concentrations J. Endocrinol. Invest. 2005, 28 (4) 346-9
62. Yu, H. Z.; Li, Z. P.; Li, S. G.; Wu, C. M. Correlations of serous levels of matrix metalloproteinases (MMP-2 and MMP-9) to invasion and metastasis of papillary thyroid carcinoma Ai Zheng. 2005, 24 (6) 740-742
63. Maeta, H.; Ohgi, S.; Terada, T. Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas Virchows Arch 2001, 438 (2) 121-8
64. Komorowski, J.; Pasieka, Z.; Jankiewicz-Wika, J.; Stepien, H. Matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases and angiogenic cytokines in peripheral blood of patients with thyroid cancer Thyroid 2002, 12 (8) 655-62
65. Hawthorn, L.; Stein, L.; Varma, R.; Wiseman, S.; Loree, T.; Tan, D. TIMP1 and SERPIN-A overexpression and TFF3 and CRABP1 underexpression as biomarkers for papillary thyroid carcinoma Head Neck 2004, 26 (12) 1069-83
66. Adav, S. S.; Li, A. A.; Manavalan, A.; Punt, P.; Sze, S. K. Quantitative iTRAQ secretome analysis of Aspergillus niger reveals novel hydrolytic enzymes J Proteome Res 2010, 9 (8) 3932-40
67. Planque, C.; Kulasingam, V.; Smith, C. R.; Reckamp, K.; Goodglick, L.; Diamandis, E. P. Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines Mol Cell Proteomics 2009, 8 (12) 2746-58
68. Fogal, V.; Sugahara, K. N.; Ruoslahti, E.; Christian, S. Cell surface nucleolin antagonist causes endothelial cell apoptosis and normalization of tumor vasculature Angiogenesis 2009, 12 (1) 91-100
69. León-Del-Río, A. Biotin-dependent regulation of gene expression in human cells The Journal of Nutritional Biochemistry 2005, 16 (7) 432-434
70. Zempleni, J.; Hassan, Y. I.; Wijeratne, S. S. Biotin and biotinidase deficiency Expert Rev Endocrinol Metab 2008, 3 (6) 715-724
71. Chen, C.-C.; Lau, L. F. Functions and mechanisms of action of CCN matricellular proteins The International Journal of Biochemistry & Cell Biology 2009, 41 (4) 771-783
72. Chen, Y.; Du, X. Y. Functional properties and intracellular signaling of CCN1/Cyr61 J Cell Biochem 2007, 100 (6) 1337-45
73. Leask, A. A sticky situation: CCN1 promotes both proliferation and apoptosis of cancer cells Journal of Cell Communication and Signaling 2009
74. Watari, H.; Kanuma, T.; Ohta, Y.; Hassan, M. K.; Mitamura, T.; Hosaka, M.; Minegishi, T.; Sakuragi, N. Clusterin Expression Inversely Correlates with Chemosensitivity and Predicts Poor Survival in Patients with Locally Advanced Cervical Cancer Treated with Cisplatin-Based Neoadjuvant Chemotherapy and Radical Hysterectomy Pathol Oncol Res 2010
75. Zellweger, T.; Chi, K.; Miyake, H.; Adomat, H.; Kiyama, S.; Skov, K.; Gleave, M. E. Enhanced radiation sensitivity in prostate cancer by inhibition of the cell survival protein clusterin Clin. Cancer Res. 2002, 8 (10) 3276-84
76. Cheruvanky, A.; Zhou, H.; Pisitkun, T.; Kopp, J. B.; Knepper, M. A.; Yuen, P. S.; Star, R. A. Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator Am J Physiol Renal Physiol 2007, 292 (5) F1657-61
77. Ghidoni, R.; Paterlini, A.; Albertini, V.; Glionna, M.; Monti, E.; Schiaffonati, L.; Benussi, L.; Levy, E.; Binetti, G. Cystatin C is released in association with exosomes: A new tool of neuronal communication which is unbalanced in Alzheimer's disease Neurobiol Aging 2009
78. Stoeck, A.; Keller, S.; Riedle, S.; Sanderson, M. P.; Runz, S.; Le Naour, F.; Gutwein, P.; Ludwig, A.; Rubinstein, E.; Altevogt, P. A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44 Biochem. J. 2006, 393 (Pt 3) 609-18
79. Jung, T.; Castellana, D.; Klingbeil, P.; Cuesta Hernandez, I.; Vitacolonna, M.; Orlicky, D. J.; Roffler, S. R.; Brodt, P.; Zoller, M. CD44v6 dependence of premetastatic niche preparation by exosomes Neoplasia 2009, 11 (10) 1093-105
80. Taylor, D. D.; Gercel-Taylor, C. Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects Br J Cancer. 2005, 92 (2) 305-311